MoneyWorks4Me

Dr. Lal Pathlabs’ arm incorporates subsidiary company in Uzbekistan

20 Aug 2026 Evaluate

Dr. Lal Pathlabs’ wholly owned subsidiary -- Dr Lal PathLabs FZCO, United Arab Emirates, has incorporated a subsidiary company in Tashkent, Uzbekistan named ‘Dr Lal PathLabs Indomed LLC’ on August 19, 2026, and has agreed to subscribe 70% of its share capital.

The objective of incorporation is to strengthen the group’s presence in Tashkent, Uzbekistan.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.


Dr. Lal Pathlabs Share Price

1892.70 4.20 (0.22%)
21-Aug-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: